Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

New product for allergic conjunctivitis recommended for E.U. approval

Feb. 27, 2002

Sucampo licenses tacrolimus from Fujisawa for ophthalmic use

Feb. 21, 2002

Mutations in optineurin responsible for adult-onset primary open-angle glaucoma

Feb. 13, 2002

Chlorambucil in the treatment of sight-threatening ocular inflammation

Feb. 7, 2002

U.S. launch of Paremyd scheduled for March

Jan. 29, 2002

Naturally occurring angiostatic agents identified by Scripps to have potential in eye diseases

Jan. 28, 2002

Allergan and EntreMed enter five-year strategic alliance in eye diseases

Jan. 24, 2002

Travatan introduced in the U.K.

Jan. 21, 2002

Disappointing preliminary results from first phase III trial of INS-3 Ophthalmic in dry eye

Jan. 17, 2002

Neurotech licenses Amgen's CNTF for ophthalmic indications

Jan. 17, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...